Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Oropharynx”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01254617
What this trial is testing

Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Colon CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+39 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT04106362
What this trial is testing

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8KRAS Protein Variant+2 more
Jonsson Comprehensive Cancer Center 1
Not applicableLooking for participantsNCT05793151
What this trial is testing

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaOropharynx Cancer+2 more
Medical University of South Carolina 532
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Large-scale testing (Phase 3)Looking for participantsNCT07441681
What this trial is testing

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+13 more
NRG Oncology
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06861712
What this trial is testing

Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Stereotactic Body Radiation Therapy (SBRT)
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Looking for participantsNCT04852328
What this trial is testing

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Washington University School of Medicine 30
Not applicableStudy completedNCT00482872
What this trial is testing

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 400
Large-scale testing (Phase 3)Study completedNCT00003139
What this trial is testing

Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral Complications
Radiation Therapy Oncology Group 249
Early research (Phase 1)WithdrawnNCT03575234
What this trial is testing

Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer

Who this might be right for
Human Papillomavirus Positive Oropharyngeal Squamous Cell CarcinomaStage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+2 more
Emory University
Testing effectiveness (Phase 2)Study completedNCT00720304
What this trial is testing

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 43
Not applicableStudy completedNCT01487733
What this trial is testing

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 155
Testing effectiveness (Phase 2)Ended earlyNCT01525927
What this trial is testing

Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity

Who this might be right for
Oropharyngeal Neoplasms
Northwell Health 2
Early research (Phase 1)Ended earlyNCT00080028
What this trial is testing

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerOropharynx CancerLarynx Cancer+1 more
Pharmacyclics LLC. 18
Large-scale testing (Phase 3)Study completedNCT00017511
What this trial is testing

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Daiichi Sankyo
Not applicableStudy completedNCT00765791
What this trial is testing

2B or Not 2B? Shoulder Function After Level 2B Neck Dissection: A Randomized Controlled Study

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Alberta 40
Testing effectiveness (Phase 2)Study completedNCT03621696
What this trial is testing

Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)"

Who this might be right for
HPV Related Oropharyngeal Squamous Cell Carcinoma
Washington University School of Medicine 63
Early research (Phase 1)Looking for participantsNCT06747390
What this trial is testing

Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (OPSCCA)Oropharyngeal CancerHuman Papilloma Virus+1 more
Ryan Carey 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07513324
What this trial is testing

Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)

Who this might be right for
HPV-positive Oropharyngeal Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Dana-Farber Cancer Institute 116
Testing effectiveness (Phase 2)Study completedNCT02002182
What this trial is testing

ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of the Head and NeckHPV Positive Oropharyngeal Squamous Cell Carcinoma
Andrew Sikora 15
Next Page
454